3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-invasive Neuromodulation Device Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-9L8360
Home | Market Reports | Health| Medical Devices & Equipment
Global and Japan Non invasive Neuromodulation Device Market Insights Forecast to 2027
BUY CHAPTERS

Global Non-invasive Neuromodulation Device Market Research Report 2025

Code: QYRE-Auto-9L8360
Report
September 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-invasive Neuromodulation Device Market

The global market for Non-invasive Neuromodulation Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Neuromodulation is "the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body". It is carried out to normalize – or modulate – nervous tissue function. It is divided into invasive and non-invasive neuromodulation, which includes ETC, Transcranial Electrical Stimulation (tES) and so on.
North American market for Non-invasive Neuromodulation Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Non-invasive Neuromodulation Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Non-invasive Neuromodulation Device include Neuroelectrics, Magstim, NeuroCare Group, Soterix Medical, Newronika, Rogue Resolutions, Medtronic, Philips Healthcare, Shenzhen Yingchi Technology, Shenzhen Hanix United, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-invasive Neuromodulation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Neuromodulation Device.
The Non-invasive Neuromodulation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-invasive Neuromodulation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-invasive Neuromodulation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-invasive Neuromodulation Device Market Report

Report Metric Details
Report Name Non-invasive Neuromodulation Device Market
Segment by Type
  • Transcranial Direct Current Stimulation (tDCS)
  • Transcranial Alternating Current Stimulation (tACS)
  • Transcranial Pulsed Current Stimulation (tPCS)
  • Transcranial Random Noise Stimulation (tRNS)
  • Electroconvulsive therapy (ECT)
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Neuroelectrics, Magstim, NeuroCare Group, Soterix Medical, Newronika, Rogue Resolutions, Medtronic, Philips Healthcare, Shenzhen Yingchi Technology, Shenzhen Hanix United, Shanghai Qiankang Medical Care Company, TCT Research, EB Neuro SpA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-invasive Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-invasive Neuromodulation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Non-invasive Neuromodulation Device Market report?

Ans: The main players in the Non-invasive Neuromodulation Device Market are Neuroelectrics, Magstim, NeuroCare Group, Soterix Medical, Newronika, Rogue Resolutions, Medtronic, Philips Healthcare, Shenzhen Yingchi Technology, Shenzhen Hanix United, Shanghai Qiankang Medical Care Company, TCT Research, EB Neuro SpA

What are the Application segmentation covered in the Non-invasive Neuromodulation Device Market report?

Ans: The Applications covered in the Non-invasive Neuromodulation Device Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Non-invasive Neuromodulation Device Market report?

Ans: The Types covered in the Non-invasive Neuromodulation Device Market report are Transcranial Direct Current Stimulation (tDCS), Transcranial Alternating Current Stimulation (tACS), Transcranial Pulsed Current Stimulation (tPCS), Transcranial Random Noise Stimulation (tRNS), Electroconvulsive therapy (ECT), Others

1 Non-invasive Neuromodulation Device Market Overview
1.1 Product Definition
1.2 Non-invasive Neuromodulation Device by Type
1.2.1 Global Non-invasive Neuromodulation Device Market Value Comparison by Type (2024 VS 2031)
1.2.2 Transcranial Direct Current Stimulation (tDCS)
1.2.3 Transcranial Alternating Current Stimulation (tACS)
1.2.4 Transcranial Pulsed Current Stimulation (tPCS)
1.2.5 Transcranial Random Noise Stimulation (tRNS)
1.2.6 Electroconvulsive therapy (ECT)
1.2.7 Others
1.3 Non-invasive Neuromodulation Device by Application
1.3.1 Global Non-invasive Neuromodulation Device Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Non-invasive Neuromodulation Device Market Size Estimates and Forecasts
1.4.1 Global Non-invasive Neuromodulation Device Revenue 2020-2031
1.4.2 Global Non-invasive Neuromodulation Device Sales 2020-2031
1.4.3 Global Non-invasive Neuromodulation Device Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-invasive Neuromodulation Device Market Competition by Manufacturers
2.1 Global Non-invasive Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-invasive Neuromodulation Device Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-invasive Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-invasive Neuromodulation Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-invasive Neuromodulation Device, Product Type & Application
2.7 Global Key Manufacturers of Non-invasive Neuromodulation Device, Date of Enter into This Industry
2.8 Global Non-invasive Neuromodulation Device Market Competitive Situation and Trends
2.8.1 Global Non-invasive Neuromodulation Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-invasive Neuromodulation Device Players Market Share by Revenue
2.8.3 Global Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-invasive Neuromodulation Device Market Scenario by Region
3.1 Global Non-invasive Neuromodulation Device Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-invasive Neuromodulation Device Sales by Region: 2020-2031
3.2.1 Global Non-invasive Neuromodulation Device Sales by Region: 2020-2025
3.2.2 Global Non-invasive Neuromodulation Device Sales by Region: 2026-2031
3.3 Global Non-invasive Neuromodulation Device Revenue by Region: 2020-2031
3.3.1 Global Non-invasive Neuromodulation Device Revenue by Region: 2020-2025
3.3.2 Global Non-invasive Neuromodulation Device Revenue by Region: 2026-2031
3.4 North America Non-invasive Neuromodulation Device Market Facts & Figures by Country
3.4.1 North America Non-invasive Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-invasive Neuromodulation Device Sales by Country (2020-2031)
3.4.3 North America Non-invasive Neuromodulation Device Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-invasive Neuromodulation Device Market Facts & Figures by Country
3.5.1 Europe Non-invasive Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-invasive Neuromodulation Device Sales by Country (2020-2031)
3.5.3 Europe Non-invasive Neuromodulation Device Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-invasive Neuromodulation Device Market Facts & Figures by Region
3.6.1 Asia Pacific Non-invasive Neuromodulation Device Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-invasive Neuromodulation Device Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-invasive Neuromodulation Device Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-invasive Neuromodulation Device Market Facts & Figures by Country
3.7.1 Latin America Non-invasive Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-invasive Neuromodulation Device Sales by Country (2020-2031)
3.7.3 Latin America Non-invasive Neuromodulation Device Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-invasive Neuromodulation Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-invasive Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-invasive Neuromodulation Device Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-invasive Neuromodulation Device Sales by Type (2020-2031)
4.1.1 Global Non-invasive Neuromodulation Device Sales by Type (2020-2025)
4.1.2 Global Non-invasive Neuromodulation Device Sales by Type (2026-2031)
4.1.3 Global Non-invasive Neuromodulation Device Sales Market Share by Type (2020-2031)
4.2 Global Non-invasive Neuromodulation Device Revenue by Type (2020-2031)
4.2.1 Global Non-invasive Neuromodulation Device Revenue by Type (2020-2025)
4.2.2 Global Non-invasive Neuromodulation Device Revenue by Type (2026-2031)
4.2.3 Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2020-2031)
4.3 Global Non-invasive Neuromodulation Device Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-invasive Neuromodulation Device Sales by Application (2020-2031)
5.1.1 Global Non-invasive Neuromodulation Device Sales by Application (2020-2025)
5.1.2 Global Non-invasive Neuromodulation Device Sales by Application (2026-2031)
5.1.3 Global Non-invasive Neuromodulation Device Sales Market Share by Application (2020-2031)
5.2 Global Non-invasive Neuromodulation Device Revenue by Application (2020-2031)
5.2.1 Global Non-invasive Neuromodulation Device Revenue by Application (2020-2025)
5.2.2 Global Non-invasive Neuromodulation Device Revenue by Application (2026-2031)
5.2.3 Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2020-2031)
5.3 Global Non-invasive Neuromodulation Device Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Neuroelectrics
6.1.1 Neuroelectrics Company Information
6.1.2 Neuroelectrics Description and Business Overview
6.1.3 Neuroelectrics Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Neuroelectrics Non-invasive Neuromodulation Device Product Portfolio
6.1.5 Neuroelectrics Recent Developments/Updates
6.2 Magstim
6.2.1 Magstim Company Information
6.2.2 Magstim Description and Business Overview
6.2.3 Magstim Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Magstim Non-invasive Neuromodulation Device Product Portfolio
6.2.5 Magstim Recent Developments/Updates
6.3 NeuroCare Group
6.3.1 NeuroCare Group Company Information
6.3.2 NeuroCare Group Description and Business Overview
6.3.3 NeuroCare Group Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.3.4 NeuroCare Group Non-invasive Neuromodulation Device Product Portfolio
6.3.5 NeuroCare Group Recent Developments/Updates
6.4 Soterix Medical
6.4.1 Soterix Medical Company Information
6.4.2 Soterix Medical Description and Business Overview
6.4.3 Soterix Medical Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Soterix Medical Non-invasive Neuromodulation Device Product Portfolio
6.4.5 Soterix Medical Recent Developments/Updates
6.5 Newronika
6.5.1 Newronika Company Information
6.5.2 Newronika Description and Business Overview
6.5.3 Newronika Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Newronika Non-invasive Neuromodulation Device Product Portfolio
6.5.5 Newronika Recent Developments/Updates
6.6 Rogue Resolutions
6.6.1 Rogue Resolutions Company Information
6.6.2 Rogue Resolutions Description and Business Overview
6.6.3 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Rogue Resolutions Non-invasive Neuromodulation Device Product Portfolio
6.6.5 Rogue Resolutions Recent Developments/Updates
6.7 Medtronic
6.7.1 Medtronic Company Information
6.7.2 Medtronic Description and Business Overview
6.7.3 Medtronic Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Medtronic Non-invasive Neuromodulation Device Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 Philips Healthcare
6.8.1 Philips Healthcare Company Information
6.8.2 Philips Healthcare Description and Business Overview
6.8.3 Philips Healthcare Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Philips Healthcare Non-invasive Neuromodulation Device Product Portfolio
6.8.5 Philips Healthcare Recent Developments/Updates
6.9 Shenzhen Yingchi Technology
6.9.1 Shenzhen Yingchi Technology Company Information
6.9.2 Shenzhen Yingchi Technology Description and Business Overview
6.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product Portfolio
6.9.5 Shenzhen Yingchi Technology Recent Developments/Updates
6.10 Shenzhen Hanix United
6.10.1 Shenzhen Hanix United Company Information
6.10.2 Shenzhen Hanix United Description and Business Overview
6.10.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shenzhen Hanix United Non-invasive Neuromodulation Device Product Portfolio
6.10.5 Shenzhen Hanix United Recent Developments/Updates
6.11 Shanghai Qiankang Medical Care Company
6.11.1 Shanghai Qiankang Medical Care Company Company Information
6.11.2 Shanghai Qiankang Medical Care Company Description and Business Overview
6.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product Portfolio
6.11.5 Shanghai Qiankang Medical Care Company Recent Developments/Updates
6.12 TCT Research
6.12.1 TCT Research Company Information
6.12.2 TCT Research Description and Business Overview
6.12.3 TCT Research Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.12.4 TCT Research Non-invasive Neuromodulation Device Product Portfolio
6.12.5 TCT Research Recent Developments/Updates
6.13 EB Neuro SpA
6.13.1 EB Neuro SpA Company Information
6.13.2 EB Neuro SpA Description and Business Overview
6.13.3 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)
6.13.4 EB Neuro SpA Non-invasive Neuromodulation Device Product Portfolio
6.13.5 EB Neuro SpA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-invasive Neuromodulation Device Industry Chain Analysis
7.2 Non-invasive Neuromodulation Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-invasive Neuromodulation Device Production Mode & Process Analysis
7.4 Non-invasive Neuromodulation Device Sales and Marketing
7.4.1 Non-invasive Neuromodulation Device Sales Channels
7.4.2 Non-invasive Neuromodulation Device Distributors
7.5 Non-invasive Neuromodulation Device Customer Analysis
8 Non-invasive Neuromodulation Device Market Dynamics
8.1 Non-invasive Neuromodulation Device Industry Trends
8.2 Non-invasive Neuromodulation Device Market Drivers
8.3 Non-invasive Neuromodulation Device Market Challenges
8.4 Non-invasive Neuromodulation Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Non-invasive Neuromodulation Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Non-invasive Neuromodulation Device Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Non-invasive Neuromodulation Device Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Non-invasive Neuromodulation Device Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Non-invasive Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Non-invasive Neuromodulation Device Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Non-invasive Neuromodulation Device Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Non-invasive Neuromodulation Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Non-invasive Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-invasive Neuromodulation Device, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-invasive Neuromodulation Device, Product Type & Application
 Table 12. Global Key Manufacturers of Non-invasive Neuromodulation Device, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-invasive Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Neuromodulation Device as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-invasive Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Non-invasive Neuromodulation Device Sales by Region (2020-2025) & (K Units)
 Table 18. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2020-2025)
 Table 19. Global Non-invasive Neuromodulation Device Sales by Region (2026-2031) & (K Units)
 Table 20. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2026-2031)
 Table 21. Global Non-invasive Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Non-invasive Neuromodulation Device Revenue Market Share by Region (2020-2025)
 Table 23. Global Non-invasive Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Non-invasive Neuromodulation Device Revenue Market Share by Region (2026-2031)
 Table 25. North America Non-invasive Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Non-invasive Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 27. North America Non-invasive Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 28. North America Non-invasive Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Non-invasive Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Non-invasive Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Non-invasive Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Non-invasive Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Non-invasive Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Non-invasive Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Non-invasive Neuromodulation Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Non-invasive Neuromodulation Device Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Non-invasive Neuromodulation Device Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Non-invasive Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Non-invasive Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non-invasive Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Non-invasive Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Non-invasive Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Non-invasive Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Non-invasive Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Non-invasive Neuromodulation Device Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Non-invasive Neuromodulation Device Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Non-invasive Neuromodulation Device Sales (K Units) by Type (2020-2025)
 Table 51. Global Non-invasive Neuromodulation Device Sales (K Units) by Type (2026-2031)
 Table 52. Global Non-invasive Neuromodulation Device Sales Market Share by Type (2020-2025)
 Table 53. Global Non-invasive Neuromodulation Device Sales Market Share by Type (2026-2031)
 Table 54. Global Non-invasive Neuromodulation Device Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Non-invasive Neuromodulation Device Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2020-2025)
 Table 57. Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2026-2031)
 Table 58. Global Non-invasive Neuromodulation Device Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Non-invasive Neuromodulation Device Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Non-invasive Neuromodulation Device Sales (K Units) by Application (2020-2025)
 Table 61. Global Non-invasive Neuromodulation Device Sales (K Units) by Application (2026-2031)
 Table 62. Global Non-invasive Neuromodulation Device Sales Market Share by Application (2020-2025)
 Table 63. Global Non-invasive Neuromodulation Device Sales Market Share by Application (2026-2031)
 Table 64. Global Non-invasive Neuromodulation Device Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Non-invasive Neuromodulation Device Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2020-2025)
 Table 67. Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2026-2031)
 Table 68. Global Non-invasive Neuromodulation Device Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Non-invasive Neuromodulation Device Price (US$/Unit) by Application (2026-2031)
 Table 70. Neuroelectrics Company Information
 Table 71. Neuroelectrics Description and Business Overview
 Table 72. Neuroelectrics Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Neuroelectrics Non-invasive Neuromodulation Device Product
 Table 74. Neuroelectrics Recent Developments/Updates
 Table 75. Magstim Company Information
 Table 76. Magstim Description and Business Overview
 Table 77. Magstim Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Magstim Non-invasive Neuromodulation Device Product
 Table 79. Magstim Recent Developments/Updates
 Table 80. NeuroCare Group Company Information
 Table 81. NeuroCare Group Description and Business Overview
 Table 82. NeuroCare Group Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. NeuroCare Group Non-invasive Neuromodulation Device Product
 Table 84. NeuroCare Group Recent Developments/Updates
 Table 85. Soterix Medical Company Information
 Table 86. Soterix Medical Description and Business Overview
 Table 87. Soterix Medical Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Soterix Medical Non-invasive Neuromodulation Device Product
 Table 89. Soterix Medical Recent Developments/Updates
 Table 90. Newronika Company Information
 Table 91. Newronika Description and Business Overview
 Table 92. Newronika Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Newronika Non-invasive Neuromodulation Device Product
 Table 94. Newronika Recent Developments/Updates
 Table 95. Rogue Resolutions Company Information
 Table 96. Rogue Resolutions Description and Business Overview
 Table 97. Rogue Resolutions Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Rogue Resolutions Non-invasive Neuromodulation Device Product
 Table 99. Rogue Resolutions Recent Developments/Updates
 Table 100. Medtronic Company Information
 Table 101. Medtronic Description and Business Overview
 Table 102. Medtronic Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Medtronic Non-invasive Neuromodulation Device Product
 Table 104. Medtronic Recent Developments/Updates
 Table 105. Philips Healthcare Company Information
 Table 106. Philips Healthcare Description and Business Overview
 Table 107. Philips Healthcare Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Philips Healthcare Non-invasive Neuromodulation Device Product
 Table 109. Philips Healthcare Recent Developments/Updates
 Table 110. Shenzhen Yingchi Technology Company Information
 Table 111. Shenzhen Yingchi Technology Description and Business Overview
 Table 112. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product
 Table 114. Shenzhen Yingchi Technology Recent Developments/Updates
 Table 115. Shenzhen Hanix United Company Information
 Table 116. Shenzhen Hanix United Description and Business Overview
 Table 117. Shenzhen Hanix United Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shenzhen Hanix United Non-invasive Neuromodulation Device Product
 Table 119. Shenzhen Hanix United Recent Developments/Updates
 Table 120. Shanghai Qiankang Medical Care Company Company Information
 Table 121. Shanghai Qiankang Medical Care Company Description and Business Overview
 Table 122. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product
 Table 124. Shanghai Qiankang Medical Care Company Recent Developments/Updates
 Table 125. TCT Research Company Information
 Table 126. TCT Research Description and Business Overview
 Table 127. TCT Research Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. TCT Research Non-invasive Neuromodulation Device Product
 Table 129. TCT Research Recent Developments/Updates
 Table 130. EB Neuro SpA Company Information
 Table 131. EB Neuro SpA Description and Business Overview
 Table 132. EB Neuro SpA Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. EB Neuro SpA Non-invasive Neuromodulation Device Product
 Table 134. EB Neuro SpA Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Non-invasive Neuromodulation Device Distributors List
 Table 138. Non-invasive Neuromodulation Device Customers List
 Table 139. Non-invasive Neuromodulation Device Market Trends
 Table 140. Non-invasive Neuromodulation Device Market Drivers
 Table 141. Non-invasive Neuromodulation Device Market Challenges
 Table 142. Non-invasive Neuromodulation Device Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-invasive Neuromodulation Device
 Figure 2. Global Non-invasive Neuromodulation Device Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-invasive Neuromodulation Device Market Share by Type: 2024 & 2031
 Figure 4. Transcranial Direct Current Stimulation (tDCS) Product Picture
 Figure 5. Transcranial Alternating Current Stimulation (tACS) Product Picture
 Figure 6. Transcranial Pulsed Current Stimulation (tPCS) Product Picture
 Figure 7. Transcranial Random Noise Stimulation (tRNS) Product Picture
 Figure 8. Electroconvulsive therapy (ECT) Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Non-invasive Neuromodulation Device Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Non-invasive Neuromodulation Device Market Share by Application: 2024 & 2031
 Figure 12. Hospital
 Figure 13. Clinic
 Figure 14. Others
 Figure 15. Global Non-invasive Neuromodulation Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Non-invasive Neuromodulation Device Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Non-invasive Neuromodulation Device Sales (2020-2031) & (K Units)
 Figure 18. Global Non-invasive Neuromodulation Device Average Price (US$/Unit) & (2020-2031)
 Figure 19. Non-invasive Neuromodulation Device Report Years Considered
 Figure 20. Non-invasive Neuromodulation Device Sales Share by Manufacturers in 2024
 Figure 21. Global Non-invasive Neuromodulation Device Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Non-invasive Neuromodulation Device Players: Market Share by Revenue in Non-invasive Neuromodulation Device in 2024
 Figure 23. Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Non-invasive Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Non-invasive Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 26. North America Non-invasive Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 27. United States Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Non-invasive Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 30. Europe Non-invasive Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Non-invasive Neuromodulation Device Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Non-invasive Neuromodulation Device Revenue Market Share by Region (2020-2031)
 Figure 38. China Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Non-invasive Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Non-invasive Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Non-invasive Neuromodulation Device Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Non-invasive Neuromodulation Device Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Non-invasive Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Non-invasive Neuromodulation Device by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Non-invasive Neuromodulation Device by Type (2020-2031)
 Figure 59. Global Non-invasive Neuromodulation Device Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Non-invasive Neuromodulation Device by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Non-invasive Neuromodulation Device by Application (2020-2031)
 Figure 62. Global Non-invasive Neuromodulation Device Price (US$/Unit) by Application (2020-2031)
 Figure 63. Non-invasive Neuromodulation Device Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart